INTRODUCTION
============

Long-term potentiation (LTP) is a form of synaptic plasticity whereby high frequency stimulation (HFS) induces a long-lasting enhancement of synaptic transmission. LTP is widely accepted as an excellent model for the molecular mechanisms that mediate long-term information storage in the brain. Many of its key properties are analogous to those of long-term memory, including input specificity, rapid induction, and co-operativity ([@B4]). Most importantly, LTP is persistent: indeed an *in vivo* study suggests that LTP can last for at least a year after induction ([@B1]). Although the potential for persistent LTP was noted in the earliest studies ([@B15]), we still do not understand how the mechanisms underlying the stabilization of synaptic change allow LTP to persist for periods of days or weeks.

MicroRNA (miRNA) are endogenous non-coding RNA that act as post-transcriptional inhibitors of protein synthesis. They function by base-pairing with miRNA response elements (MREs) located in target messenger RNA (mRNA). This occurs within the ribonuclear protein complex known as the RNA-induced silencing complex (RISC; [@B52]). To date, 2588 unique mature human miRNA have been annotated (miRBase 21). MiRNA are predicted to regulate the activity of more than 60% of human protein-coding genes ([@B36]), although others predict far fewer in humans (30%; [@B71]) and in *Caenorhabditis elegans* (10%; [@B65]). Even considering the most conservative estimates, the potential impact of miRNA activity on protein expression is profound. MiRNA are present in all body tissues ([@B67]), and their stability in circulating fluids suggests that they play an important role in cell--cell communication ([@B21]) and have utility as biomarkers of disease ([@B31]). Further, specific miRNA are crucial for development and function of both neurons and glia ([@B105]) and miRNA dysfunction is associated with neurodegenerative diseases, including Alzheimer's disease (AD), which is characterized by memory impairment ([@B25]; [@B56]).

While recent reviews have detailed miRNA regulation at synapses ([@B114]; [@B115]), their potential role as biomarkers of neurological disease ([@B110]) and highlighted the involvement of miRNA in a wide range of synaptic processes, from neurotransmission ([@B44]) to morphology ([@B81]), miRNA function in LTP has not been addressed specifically. To address this gap in the literature, this review will summarize experimental evidence for the proposal that miRNA play a major role in the regulation of LTP.

LONG-TERM POTENTIATION
----------------------

LTP is not a unitary phenomenon: multiple forms exist distinguished by stimulation paradigm, experimental preparation and brain region. While LTP can be induced in the visual cortex and a variety of cortical and subcortical structures ([@B1]; [@B26]; [@B136]; [@B24]), the majority of LTP research focuses on the hippocampus, a memory-related structure with a robust circuitry that lends itself well to experimentation. Here, LTP can be triggered not only by electrical stimulation (e.g., theta-burst, delta-burst), activation of metabotropic glutamate receptors (mGluRs) and brain-derived neurotrophic factor/tropomyosin receptor kinase B (BDNF/TrkB) signaling ([@B16]; [@B7]; [@B46]; [@B106]) but by learning itself ([@B123]). This, alongside the remarkable persistence of LTP at hippocampal perforant path-dentate gyrus synapses, provides compelling evidence for the involvement of LTP-type plasticity in memory function.

Long-term potentiation induced at perforant path synapses in awake freely moving animals consists of three temporally and mechanistically distinct canonical phases: LTP1, LTP2, and LTP3 ([@B2]). LTP1 refers to the initial, rapid strengthening of synapses, independent of protein synthesis and lasting for a few hours at most ([@B97]; [@B2]). The putative cellular mechanisms that underlie LTP1, including enhanced release of neurotransmitter ([@B12]), protein kinase activation ([@B104]; [@B73]), and trafficking of both α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and *N*-methyl-[D]{.smallcaps}-aspartate (NMDA) subtypes of glutamate receptors to synapses ([@B129]; [@B43]; [@B111]), are likely to only explain short term synaptic strengthening. In contrast, the latter two phases require new protein synthesis. LTP2, the intermediate phase, requires synaptically localized protein synthesis but not new gene transcription, and has an average decay time constant of a few days ([@B91]; [@B51]). However, as dendrites cannot maintain LTP for long periods of time when physically separated from their cell bodies ([@B51]), translation of extant mRNA alone cannot explain LTP stabilization. The most long-lasting phase, LTP3, is dependent on new gene transcription as well as translation and can last for periods of weeks when induced at perforant path synapses ([@B88]; [@B1]). Here, the gene expression changes that accompany LTP maintenance have been intensively studied ([@B3]).

Indeed, recent microarray studies have identified many LTP-induced, co-regulated genes, supporting the concept that LTP persistence involves regulation of coordinated gene networks ([@B70]; [@B94]; [@B124]; [@B42]). Our recent studies have shown that the LTP-related transcriptional response is not limited to periods of minutes following LTP but extends to hours and days ([@B101], [@B102]). Bioinformatic analysis of this data set using Ingenuity Pathway Analysis (IPA) algorithms predicts this ongoing transcriptional response contributes both to dynamic alteration of synapses, through regulation of calcium dynamics, protein kinases, and synaptogenesis, and higher level regulation of gene expression. Intriguingly, this analysis predicted that miRNA functioned as regulatory hubs in these networks. This result suggests that complex processes such as LTP, involving the coordinated regulation of gene networks, may require fine-tuning of protein synthesis by miRNA, acting alongside other translational regulators ([@B18]; [@B116]; [@B50]).

MicroRNA BIOGENESIS AND FUNCTION: KEY CHARACTERISTICS RELEVANT TO LTP
---------------------------------------------------------------------

We propose that miRNA are ideally suited to control the rapid, coordinated and region-specific translation that underlies LTP maintenance. The characteristics of miRNA biogenesis and function that are of particular interest in this regard are tight spatial and temporal control of miRNA expression, their ability to function in a combinatorial manner with other miRNA, and the ability of a single miRNA to coordinate the expression of many mRNA related by their MRE sequences.

### microRNA function

Mature miRNA range from 15 to 34 nucleotides in length and their average length is 22 nucleotides (miRBase 21). The functional impact of miRNA binding depends primarily on the thermo-stability of base-pairing between the target mRNA MRE and the miRNA 5^′^-seed sequence (nucleotides 2--8; [@B10]); the 3^′^ region of the miRNA affects function to a lesser degree ([@B27]). MiRNA usually interact with MREs in the 3^′^-untranslated region (UTR) of target mRNA ([@B10]); yet the 5^′^-UTR and protein-coding regions can also contain functional MREs ([@B78]; [@B35]), though the effect may be marginal ([@B40]). In animals, complementarity between miRNA and their mRNA targets is typically imperfect ([@B9]); this creates an internal bulge structure that distorts the helix, thereby preventing mRNA cleavage but allowing translational repression ([@B135]; [@B99]). The exact mechanisms of RISC-induced translational repression are still under debate (reviewed by [@B86]), however, translational repression is generally coupled ultimately with mRNA degradation via deadenylation ([@B32]) and decapping ([@B13]). Infrequently, imperfect miRNA:mRNA base-pairing can cause translational repression without mRNA degradation, which may be reversible ([@B14]; [@B107]). In contrast, perfect or near-perfect base-pairing can result in mRNA degradation via endonucleolytic cleavage, but this is very rare in animals ([@B134]). Intriguingly, miRNA have been shown to up-regulate translation under some circumstances in mammals ([@B122]; [@B90]).

### microRNA biogenesis

MiRNA biogenesis consists of three major processes: transcription of a much longer primary transcript (pri-miRNA), followed by two consecutive cleavage events initiated by the RNase III enzymes Drosha and Dicer, which generate a precursor miRNA (pre-miRNA) and ultimately liberate the mature miRNA (**Figure [1](#F1){ref-type="fig"}**). Note that both the 5^′^ or 3^′^ strands of the miRNA hairpin can release a functional miRNA and these are denoted as, e.g., miR-132-5p or miR-132-3p respectively. Precise control of miRNA expression can be modulated at multiple points throughout this pathway ([@B118]). In addition, pri- and pre-miRNA can be modified via RNA editing, affecting their activity ([@B96]). There is also evidence that turnover of some neuronal miRNA is activity-dependent ([@B61]), and tightly regulated (reviewed in [@B62]), although this is less well understood than miRNA biogenesis.

![**MicroRNA biogenesis and mechanism of action.** See text for details.](fnmol-08-00004-g001){#F1}

### Tight spatial and temporal control

As miRNA are functional immediately after transcription and processing, they can respond more rapidly to external stimuli than transcription factors, which require translation into protein, transportation to the nucleus, and often post-translational modification to regulate gene expression. Tight spatial and temporal control of miRNA activity could allow miRNA to regulate translation selectively at individual synapses. This hypothesis is supported by the observation that both pri- and pre-miRNA, as well as their cleavage partners Drosha, DGCR8 and Dicer, are located at mouse hippocampal post-synaptic densities (PSDs; [@B75], [@B74]). Under normal conditions, Dicer was shown to be inactive in the PSD; however, following synaptic activation, the release of calcium caused calpain, a proteolytic enzyme, to activate Dicer, thereby triggering the conversion of pre-miRNA into active, mature miRNA ([@B75]). Furthermore, pri-miRNA were found to be highly enriched with RNA transport granules, suggesting they can be transported alongside mRNA and processed at the PSD ([@B74]). These important studies suggest that the expression of mature miRNA can be locally regulated by activity, providing a possible mechanism for translational regulation specific to activated synapses, thus contributing to the input specificity of LTP.

### microRNA are highly pleiotropic

Individual miRNA can coordinately regulate the translation of many mRNA that share the same or similar MRE sequences, as complete complementation is not required for miRNA activity ([@B60]). Indeed, [@B109] demonstrated that one miRNA can not only promote degradation of hundreds of mRNA transcripts, but also repress the production of hundreds of additional proteins at the level of translation. Furthermore, the short sequences involved in miRNA:mRNA interactions make them well-suited for combinatorial effects with other miRNA or RNA-binding proteins that associate with separate sites on the same target mRNA ([@B60]). There is experimental evidence that multiple miRNA regulate the expression of the activity related cytoskeletal protein (Arc); in some cases in an additive manner ([@B125]). Additionally, there is evidence that miRNA act co-operatively with fragile X mental retardation protein (FMRP), an RNA-binding protein, known to regulate the translation of plasticity-associated mRNA ([@B131]). FMRP inhibits translation of Arc and CaMKIIα (calcium/calmodulin-dependent protein kinase IIα; [@B11]) and *Fmr1* knockout mice exhibit impaired LTP at CA1 synapses ([@B66]). FMRP is also associated with a number of miRNA in the mouse brain, including miR-132-3p, miR-125b-5p, miR-138-5p, and miR-124-3p ([@B30]), the last mediated by the FMRP Drosophila homolog dFMR1 to inhibit dendritic arbor ([@B131]). Furthermore, mouse models of fragile X syndrome showed regulation of miR-9a-5p and miR-124-3p by the FMRP family protein, FXR1P, which forms a complex with Dicer and affects miRNA processing ([@B132]). Interestingly, FXR1P has been found to be subjected to miRNA inhibition, creating a feedback loop that is becoming more evident in gene networks ([@B20]). These feedback loops imply a homeostatic role for miRNA. It is noteworthy that many miRNA targets are regulatory genes such as transcription factors ([@B121]) thus extending the range of genes regulated by one miRNA beyond those that it interacts with directly.

MicroRNA ARE REGULATED IN RESPONSE TO LONG-TERM POTENTIATION
============================================================

If miRNA regulate LTP-related protein synthesis, we would expect to see a change in the level of active, mature miRNA in response to LTP induction. LTP induced *in vitro* has been shown to regulate miRNA levels ([@B95]; [@B68]), however, the Bramham laboratory was the first to investigate miRNA expression after LTP induction in the dentate gyrus *in vivo* ([@B126], [@B125]). Using anesthetized rats, they confirmed differential expression of three miRNA in dentate gyrus tissue 2 h after induction: miR-132-3p and miR-212-3p were up-regulated, and miR-219a-5p was down-regulated. Surprisingly, when HFS was delivered in the presence of an NMDA receptor antagonist expression of all three regulated miRNA was enhanced, despite ablation of LTP, suggesting that NMDA receptor activity represses miRNA levels. In contrast, regulation of the miRNA was blocked by a group 1 mGluR antagonist, which also prevented activity-dependent depotentiation, leading to the conclusion that differential expression of miRNA was functionally correlated with reversal of LTP.

By contrast, our recent work using an *in vivo* awake rat model ([@B1]; [@B17]) and Affymetrix miRNA arrays showed that at 20 min post-LTP the majority of the 65 differentially expressed mature miRNA transcripts were down-regulated, including miR-132-3p and miR-34a-5p ([@B49]). These data contrast with the work of [@B126], [@B125]), who found no apparent rapid regulation of miR-34a-5p or miR-132-3p, and [@B92], who reported rapid up-regulation of miR-34a-5p, with no change in miR-132-3p levels. These discrepancies may potentially be accounted for by differences in stimulation paradigms and normalization procedures. Our data, interpreted alongside the generalized up-regulation of mRNA transcripts 20 min post-LTP ([@B101], [@B102]), suggest that down-regulation of miRNA may contribute to the long-term changes that lead to LTP persistence by rapidly releasing inhibition of target mRNA transcripts. We have also quantified miRNA expression at later time points using our *in vivo* awake rat model. While miR-132-3p had returned to baseline by 5 h, miR-34a-5p remained down-regulated ([@B102]; [@B49]) alongside miR-24-3p ([@B102]); a finding consistent with the prediction that miR-34a-5p and miR-24-3p target mRNA that are up-regulated 5 h post-LTP ([@B102]). As expression of these miRNA returned to baseline by 24 h, these results support the hypothesis that translational suppression of mRNA is released during the late phase of LTP to allow consolidation of LTP. Interestingly, using reverse transcription-quantitative polymerase chain reaction (RT-qPCR), we showed that the observed down-regulation of miR-34a-5p and miR-132-3p was mediated by NMDA receptors. Indeed, NMDA receptor antagonism in combination with tetanic stimulation led to a highly variable increase in miR-34a-5p, revealing an accord with [@B126] and suggesting that in awake animals, the NMDA receptor-mediated reduction of miRNA levels out-competes an independent process working to increase them.

Very recently, [@B92] have questioned the assumption that the quantity of total miRNA accurately represents miRNA activity. Instead, they have quantified miRNA bound to Ago2, one of the four Argonaute family proteins that can anchor mature miRNA within the RISC and allow miRNA activity. Using Ago2 immunoprecipitation, locked nucleic acid (LNA)-based microarrays and RT-qPCR validation, they demonstrated differential expression of Ago2-bound miRNA after LTP induction in the dentate gyrus of anesthetized rats (see **Table [1](#T1){ref-type="table"}** for details). This differential expression was quantitatively and qualitatively different to that measured in whole dentate gyrus lysate. Ago2 immunoprecipitate/whole lysate ratios indicated that eight miRNA associated with Ago2 in response to LTP induction, while three miRNA dissociated from Ago2 in response to LTP induction.

###### 

Differential expression of miRNA after LTP induction.

  Study     Organism                             Preparation                                                                     LTP induction           Time-points post-LTP induction   Identification of candidate miRNA                                                                                                       Control                                     Criteria for differential expression                      Differentially expressed miRNA determined by RT-qPCR validation
  --------- ------------------------------------ ------------------------------------------------------------------------------- ----------------------- -------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------- --------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  [@B49]    4--6 months old Sprague Dawley rat   Dentate gyrus; LTP *in vivo*, un-anesthetized                                   HFS to PP-GC synapses   20 min, 5 and 24 h               Affymetrix microarray: 65/6,703 miRNA had FC ≥ 1.15; *n* = 4                                                                            Unstimulated hemisphere (within animal)     FC ≥ 1.15; *p* \< 0.05: paired *t*-test                   miR-34a-5p down-regulated at 20 min (FC = 0.44 ± 0.07; *n* = 8) and 5 h (FC = 0.53 ± 0.16; *n* = 5); back to baseline at 24 h miR-132-3p down-regulated at 20 min (FC = 0.37 ± 0.11; *n* = 8); back to baseline at 5 h and 24 h
  [@B68]    4--5 weeks old Sprague Dawley rat    Hippocampal slice                                                               Chemical LTP            30, 60, 120 min                  Agilent microarray: 5/287 miRNA had FC ≥ 1.5 at at least one time-point; *n* = 1                                                        Slices that did not undergo LTP induction   FC ≥ 1.5; *p* \< 0.05: one-way ANOVA and LSD *post hoc*   miR-188-5p up-regulated at 60 min (FC = 1.75 ± 0.3; *n* = 3); no regulation at 30 min or 120 min. Four other miRNA (unidentified) were not regulated at any time-points
  [@B92]    Adult Sprague Dawley rat             Dentate gyrus; LTP *in vivo*, anesthetized. Total lysate and Ago2 IP examined   HFS to PP-GC synapses   30, 120 min                      miRCURY microarray: 44/376 miRNA differentially expressed (*p* \< 0.05: Student's *t*-test with Dunn--Bonferroni correction); *n* = 3   Unstimulated hemisphere (within animal)     *p* \< 0.05; one-way ANOVA                                Total lysate: miR-384-3p, miR-29b-3p, miR-219a-5p, miR-592-5p, miR-20a-5p, let-7f-5p, miR-338-3p, miR-212-3p, miR-34a-5p, miR-19a-3p, miR-326-3p up-regulated at 30 min; miR-223-3p down-regulated at 30 min. Ago2 IP: miR-384-3p, miR-29b-3p, miR-219a-5p, miR-592-5p, miR-20a-5p, let-7f-5p, miR-338-3p, miR-330-5p, miR-223-3p, miR-34a-5p, miR-19a-3p up-regulated at 30 min; miR-212-3p down-regulated at 30 min
  [@B95]    7--8 weeks old C57/BL6 mice          Hippocampal slice                                                               Chemical LTP            0, 15, 30, 60, 120 min           GenoExplorer microarray: 55/237 miRNA had mean FC over all time-points ≥ 2; *n* = 1                                                     Slices that did not undergo LTP induction   FC ≥ 2                                                    miR-181b-5p not regulated at any time-point (*n* = 10); miR-128a-3p not regulated at any time-point (*n* = 10)
  [@B102]   4--6 months old Sprague Dawley rat   Dentate gyrus; LTP *in vivo*, un-anesthetized                                   HFS to PP-GC synapses   5 h                              IPA network analysis: miRNA identified as hubs in LTP-related gene networks                                                             Unstimulated hemisphere (within animal)     FC ≥ 1.15; *p* \< 0.05: paired *t*-test                   miR-34a-5p down-regulated (FC = 0.53 ± 0.16; *n* = 5); miR-24-3p down-regulated (FC = 0.59 ± 0.12; *n* = 9)
  [@B126]   Adult Sprague Dawley rat             Dentate gyrus; LTP *in vivo*, anesthetized                                      HFS to PP-GC synapses   10, 120 min                      LC Sciences microarray: 21/237 miRNA had FC ≥ 1.2 at 120 min; *n* = 2                                                                   Unstimulated hemisphere (within animal)     FC ≥ 1.20; *p* \< 0.05: *t*-test                          miR-132-3p up-regulated at 120 min (FC = 1.38; *n* = 8); miR-212-3p up-regulated at 120 min (FC = 1.26; *n* = 8); miR-219a-5p down-regulated at 120 min (FC = 0.68; *n* = 8). None of the three miRNA were regulated at 10 min (*n* = 5)
  [@B125]   Adult Sprague Dawley rat             Dentate gyrus; LTP *in vivo*, anesthetized                                      HFS to PP-GC synapses   30, 120 min                      Arc-targeting miRNA                                                                                                                     Unstimulated hemisphere (within animal)     FC ≥ 1.20; *p* \< 0.05: *t*-test                          miR-132-3p up-regulated at 120 min (FC = ∼1.6; *n* = 5); not regulated at 30 min. No regulation of miR-19a-3p, miR-34a-5p, miR-326-3p, miR-193a-3p at 30 min or 120 min

Ago2 IP, Argonaute 2 immunoprecipitates; FC, fold change; GC, granule cell; h, hour; HFS, high frequency stimulation; IPA, Ingenuity Pathway Analysis; LSD, least significant difference; LTP, long-term potentiation; min, minute; PP, perforant path; RT-qPCR, real time-quantitative polymerase chain reaction. Data are presented as mean ± SEM.

Collectively, these data (summarized in **Table [1](#T1){ref-type="table"}**) demonstrate that individual miRNA are regulated between 20 min and 5 h after LTP induction, supporting the theory that miRNA mediate LTP-related protein synthesis. There is little overlap in the miRNA found to be differentially expressed in these seven studies, this may however be due to variation in the models used to induce LTP or differences in statistical analyses. MiR-34a-5p and miR-132-3p are the only miRNA that have been reported as differentially expressed in response to LTP by multiple laboratories. One study characterized the plasticity properties of a miR-132-3p/miR-212-3p double knockout mouse, and reported enhanced theta burst LTP in hippocampal slices, but no effect on tetanic LTP ([@B100]). Expression of both mRNA and protein products of potential miR-132-3p targets was unchanged, which may explain why tetanic LTP was not affected.

MicroRNA REGULATE LTP-RELATED GENES
===================================

The putative molecular mechanisms underpinning LTP maintenance include enhanced release of neurotransmitter, alongside enhanced post-synaptic responsiveness driven initially by activation of protein kinases and glutamate receptor trafficking, which is ultimately underpinned by altered gene expression and structural reorganization of synaptic connections ([@B3]; [@B77]). The following sections discuss the mounting evidence suggesting that individual miRNA interact with transcripts coding for proteins important to all aspects of the maintenance of LTP. These studies are summarized in **Figure [2](#F2){ref-type="fig"}** and **Table [2](#T2){ref-type="table"}**.

###### 

Evidence for miRNA regulation of LTP-related genes.

  Function                             miRNA                                          mRNA                    miRNA:mRNA interaction                                                                                                                      Further information                                                                                                                                                                                                                                     Reference
  ------------------------------------ ---------------------------------------------- ----------------------- ------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------
  Pre-synaptic vesicle release         miR-485-5p                                     SV2A                    Direct inhibition *in vitro*                                                                                                                MiR-485-5p decreased the number of vesicles released after depolarization                                                                                                                                                                               [@B23]
                                       miR-34a-5p                                     SYN1, SYN2              Inhibition *in vitro*                                                                                                                       MiR-34a-5p down-regulated 20 min ([@B49]) and 5 h after LTP induction ([@B102]); not regulated 30 min or 2 h after LTP induction ([@B125])                                                                                                              [@B5]
                                       miR-34a-5p                                     SYT1, STX-1A            Direct inhibition *in vitro*                                                                                                                Increased miR-34a-5p correlated with decreased SYT1 and STX-1A in human Alzheimer's disease (AD) brain. MiR-34a-5p down-regulated 20 min ([@B49]) and 5 h after LTP induction ([@B102]); not regulated 30 min or 2 h after LTP induction ([@B125])      [@B5]
                                       miR-25-3p miR-185-5p                           SERCA2                  Decreased miR-25-3p and miR-185-5p correlated with increased SERCA2 *in vivo*                                                               Decreased miR-25-3p and miR-185-5p linked to increased LTP in Schizophrenia mouse model                                                                                                                                                                 [@B29]
  Glutamate receptor regulation        miR-34a-5p miR-326-3p miR-19a-3p miR-193a-3p   Arc                     Direct inhibition *in vitro*                                                                                                                MiR-34a-5p, miR-326-3p, miR-19a-3p, miR-193a-3p not regulated 30 min or 2 h after LTP induction. MiR-34a-5p down-regulated 20 min ([@B49]) and 5 h after LTP induction *in vivo* ([@B102]); not regulated 30 min or 2 h after LTP induction ([@B125])   [@B125]
                                       miR-181a-5p                                    GluA2                   Direct inhibition *in vitro* (minimal)                                                                                                      MiR-181a-5p reduced spine volume and density in hippocampal neurons                                                                                                                                                                                     [@B30], [@B103]
                                       miR-138-5p                                     GluA2                   Inhibition *in vitro*                                                                                                                       MiR-138-5p reduced spine volume in hippocampal neurons (APT-1 dependent)                                                                                                                                                                                [@B113]
                                       miR-485-5p                                     GluA2                   Inhibition *in vitro*                                                                                                                       MiR-485-5p reduced spine density and increased immature spines in hippocampal neurons                                                                                                                                                                   [@B23]
                                       miR-124-3p                                     GluA2                   Direct inhibition *in vitro* (minimal)                                                                                                      --                                                                                                                                                                                                                                                      [@B30]
                                       miR-132-3p                                     GluA1, GluN2A, GluN2B   Indirect up-regulation *in vitro*                                                                                                           MiR-132-3p up-regulated 2 h after LTP induction ([@B126], [@B125]); miR-132-3p down-regulated 20 min after LTP induction ([@B49])                                                                                                                       [@B53]
                                       miR-219a-5p                                    GluA1                   Direct inhibition of CaMKIIy *in vivo*, which regulates GluA1                                                                               MiR-219a-5p down-regulated 2 h after LTP induction ([@B126])                                                                                                                                                                                            [@B58]
                                       miR-125b-5p                                    GluN2A                  Direct inhibition *in vitro*                                                                                                                MiR-125b-5p reduced spine width and increased length in hippocampal neurons (FMRP- dependent)                                                                                                                                                           [@B30]
                                       miR-212-3p                                     BDNF                    Indirect inhibition via MeCP2 *in vivo*                                                                                                     --                                                                                                                                                                                                                                                      [@B47]
                                       miR-132-3p                                     BDNF                    miR-132-3p indirectly inhibits BDNF via MeCP2; BDNF indirectly up-regulates miR-132-3p via TrkB and ERK1/2                                  MiR-132-3p up-regulated 2 h after LTP induction ([@B126], [@B125]); miR-132-3p down-regulated 20 min after LTP induction ([@B49])                                                                                                                       [@B57], [@B53]
                                       miR-206-3p                                     BDNF                    Direct inhibition *in vivo*                                                                                                                 MiR-206-3p up-regulated in Tg2576 AD mice and human AD brain samples. Intraventricular injection of miR-206-3p antagomir increased BDNF and improved memory                                                                                             [@B69]
  Transcription                        miR-132-3p                                     MeCP2                   Reciprocal inhibition: MeCP2 inhibits miR-132-3p *in vitro*; miR-132-3p inhibits MeCP2 *in vivo*; MeCP2 KO decreased miR-132-3p *in vivo*   MiR-132-3p up-regulated 2 h after LTP induction ([@B126], [@B125]); miR-132-3p down-regulated 20 min after LTP induction ([@B49])                                                                                                                       [@B57], [@B41], [@B47], [@B120]
                                       miR-212-3p                                     MeCP2                   Reciprocal inhibition: MeCP2 inhibits miR-132 *in vitro*; miR-212-3p inhibits MeCP2 *in vivo*                                               MiR-212-3p up-regulated 2 h after LTP induction ([@B126])                                                                                                                                                                                               [@B47]
                                       miR-34c-5p                                     SIRT1                   Direct inhibition *in vivo*                                                                                                                 Increased miR-34c-5p correlated with decreased SIRT1 in memory impairment mouse models (APPS1-21 and aged)                                                                                                                                              [@B137]
                                       miR-124-3p                                     CREB, EGR1              Direct inhibition *in vitro*                                                                                                                --                                                                                                                                                                                                                                                      [@B98], [@B133]
                                       miR-134-5p                                     CREB                    Direct inhibition *in vitro*                                                                                                                --                                                                                                                                                                                                                                                      [@B38]
  Activity-dependent dendritogenesis   miR-134-5p                                     Pum2                    Direct inhibition *in vitro*                                                                                                                Interaction only occurs after neuronal activity, not under basal conditions; miR-134-5p buffers Pum2 in a narrow range that is critical for activity-dependent dendritogenesis. MiR-134-5p decreased spine volume in hippocampal neurons                [@B107], [@B33]
                                       miR-134-5p                                     Limk1                   Direct inhibition *in vitro*                                                                                                                Inhibition of Limk1 in dendrites relieved by BDNF                                                                                                                                                                                                       [@B107]
                                       miR-132-3p                                     p250GAP                 Direct inhibition *in vitro* and *in vivo*                                                                                                  p250GAP regulates existing spine growth via Rac1 and kalirin-7; miR-132-3p affects spine size *in vivo*. MiR-132-3p up-regulated 2 h after LTP induction ([@B126], [@B125]); miR-132-3p down-regulated 20 min after LTP induction ([@B49])              [@B48], [@B82]
                                       miR-138-5p                                     APT1                    Direct inhibition *in vitro*                                                                                                                MiR-138-5p and APT1 co-localized at the synapse; miR-138-5p reduced spine volume in hippocampal neurons (APT-1 dependent)                                                                                                                               [@B8], [@B113]
                                       miR-19b-3p                                     PTEN                    Inhibition *in vitro*                                                                                                                       MiR-19b-3p up-regulated after fear conditioning; miR-19b-3p increased total neurite length in hippocampal neurons                                                                                                                                       [@B64]
                                       miR-188-5p                                     Nrp2                    Direct inhibition *in vitro*                                                                                                                MiR-188-5p has no effect on dendritogenesis in hippocampal neurons MiR-188-5p is up-regulated 1 h after LTP induction ([@B68])                                                                                                                          [@B68]

AD, Alzheimer's disease; APT1, acyl-protein thioesterase 1; ARC, activity-related cytoskeleton-associated protein; BDNF, brain-derived neurotrophic factor; CaMKIIγ, calcium/calmodulin-dependent protein kinase II gamma; CREB, cAMP response element-binding protein; EGR1, early growth response 1; GluA1, glutamate receptor, ionotropic, AMPA 1; GluA2, glutamate receptor, ionotropic, AMPA 2; GluN2A, glutamate receptor, ionotropic, NMDA 2A; GluN2B, glutamate receptor, ionotropic, NMDA 2B; LIMK1, LIM domain kinase 1; LTP, long-term potentiation; MECP2, methyl CpG binding protein 2; NRP2, neurophilin 2; PTEN, phosphatase and tensin homolog; PUM2, pumilio homolog 2; SERCA2, sarco/endoplasmic reticulum Ca

2+

ATPase; SIRT1, sirtuin 1; STX1A, syntaxin 1a; SV2A, synaptic vesicle glycoprotein 2A; SYN1, synapsin I; SYN2, synapsin II; SYT1, synaptotagmin I.

![**Multi-level contribution of microRNA to synaptic plasticity.** MicroRNA likely influence the translation of multiple mRNA important in specific aspects of synaptic plasticity including neurotransmitter release, AMPA and NMDA receptor subunit levels, dendritic spine size, and gene transcription. APT1, acyl-protein thioesterase 1; ARC, activity-related cytoskeleton-associated protein; BDNF, brain-derived neurotrophic factor; CaMKIIγ, calcium/calmodulin-dependent protein kinase II gamma; CREB, cAMP response element-binding protein; EGR1, early growth response 1; GluA1, glutamate receptor, ionotropic, AMPA 1; GluA2, glutamate receptor, ionotropic, AMPA 2; GluN2A, glutamate receptor, ionotropic, NMDA 2A; GluN2B, glutamate receptor, ionotropic, NMDA 2B; LIMK1, LIM domain kinase 1; MECP2, methyl CpG binding protein 2; MEF2, myocyte enhancer factor-2; NRP2, neurophilin 2; PTEN, phosphatase and tensin homolog; PUM2, pumilio homolog 2; SERCA, sarco/endoplasmic reticulum Ca^2+^ ATPase; SIRT1, sirtuin 1; STX1A, syntaxin 1a; SV2A, synaptic vesicle glycoprotein 2A; SYN1, synapsin I; SYN2, synapsin II; SYT1, synaptotagmin I.](fnmol-08-00004-g002){#F2}

MicroRNA REGULATE PRESYNAPTIC VESICLE RELEASE
---------------------------------------------

MiRNA have been found within biochemical preparations that are enriched for presynaptic terminals ([@B130]). Intriguingly, three miRNA (miR-29a-3p, miR-99a-5p, miR-125a-5p) were shown to be released from synaptosomes in a calcium-dependent manner, and miR-125a-5p was shown to be endocytosed. Collectively, these findings led the authors to propose that miRNA release and uptake from nerve terminals may contribute to intercell communication. Other miRNA have also been implicated in the regulation of neurotransmitter release. MiR-25-3p and miR-185-5p target sarco/endoplasmic reticulum Ca^2+^ ATPase (SERCA2), which is involved in the maintenance of Ca^2+^ in the endoplasmic reticulum ([@B29]). Interestingly, SERCA2 is over-expressed in a mouse model of schizophrenia, concomitant with decreased miR-25-3p and miR-185-5p expression. As a result, calcium in the presynaptic terminal was increased, leading to increased neurotransmitter release and increased LTP. Restoration of these two miRNA attenuated the enhanced LTP.

Furthermore, two miRNA, miR-485-5p and miR-34a-5p, have been shown to interact with a number of transcripts that code for synaptic vesicle proteins (**Table [2](#T2){ref-type="table"}**). Of these, synapsin 1a (SYN1), synaptotagmin I (SYT1), and syntaxin 1a (STX1A) have been implicated in LTP; SYN1 and SYT1 are regulated in response to LTP (reviewed in [@B3]) and knockout of STX1A, a t-SNARE protein, impairs LTP in hippocampal slices ([@B37]). While differential expression of miR-485-5p after LTP induction has not been reported, as outlined above, miR-34a-5p is down-regulated rapidly following LTP, the functional result of which may be to release inhibition of the synthesis of presynaptic vesicle proteins thereby contributing to enhanced release of neurotransmitter. Consistent with this hypothesis, miR-34a-5p is up-regulated in human AD, concomitant with SYT1 and STX1A down-regulation ([@B5]).

MicroRNA REGULATE GLUTAMATE RECEPTOR SUBUNITS
---------------------------------------------

AMPA and NMDA glutamate receptors both play critical roles in LTP. Early work from our laboratory has shown that the levels of both AMPA and NMDA receptor subunits are dynamically regulated in the dentate gyrus in response to perforant path LTP ([@B129], [@B127], [@B128]; [@B54], [@B55]). Interestingly, the rapid up-regulation of AMPA receptors is not due to an increase in their synthesis, but to movement of receptor subunits into the membrane from an extrasynaptic pool ([@B112]; [@B128]; [@B39]). However, protein synthesis still plays an important role as it can affect NMDA receptor expression ([@B128]) putatively through the regulation of associated chaperone molecules. To date glutamate receptor subunits have been shown to be regulated by seven miRNA (miR-132-3p, miR-124-3p, miR-125b-5p, miR-138-5p, miR-181a-5p, miR-219a-5p, and miR-485-5p); including indirect up-regulation mediated through miR-132-3p ([@B58]; [@B113]; [@B30]; [@B53]; [@B23]; [@B103]). Recently, [@B125] showed that a group of miRNA, including miR-34a-5p, regulates Arc, which is involved with trafficking AMPA receptors out of the synapse ([@B125]). These miRNA were not found to be regulated 30 min or 2 h after LTP induction; however, *in situ* hybridization and analysis of synaptoneurosome preparations showed that these Arc-targeting miRNA were synaptically expressed, suggesting basal inhibition of Arc.

MiRNA may also influence glutamate receptor subunit expression via regulation of BDNF, which is thought to contribute to the sustained structural and functional changes underlying LTP ([@B93]). MiR-206-3p directly inhibits BDNF, and is up-regulated in AD ([@B69]). Intra-ventricular injection of miR-206-3p antagomir increased BDNF expression in a mouse model of AD and improved memory function ([@B69]). Additionally, miR-212-3p decreases BDNF protein expression in the dorsal striatum *in vivo* via inhibition of methyl CpG binding protein 2 (MeCP2; [@B47]). *In vitro*, MeCP2 induces BDNF III mRNA expression and miR-132-3p decreases BDNF III mRNA expression in an MeCP2-dependent manner ([@B57]). This inhibition is significant as miR-132-3p inhibition can partially reduce BDNF-induced up-regulation of glutamate receptor subunits ([@B53]). Interestingly, BDNF has been shown to up-regulate miR-132-3p via the kinases TrkB and ERK1/2, suggesting a form of self-regulation through miRNA ([@B53]). These interactions between MeCP2, BDNF, and miR-132-3p/miR-212-3p are complex and need to be investigated further in the context of LTP. Together these data suggest that miRNA act co-operatively to regulate the expression of glutamate receptor subunits post-LTP.

MicroRNA REGULATE LTP-RELATED TRANSCRIPTION FACTORS
---------------------------------------------------

While synthesis of proteins from extant mRNA is sufficient for LTP2, the concurrent and additional activation and regulation of transcription leads to the long-term stability of memory and LTP3 *in vivo*. Five miRNA (miR-34c-5p, miR-124-3p, miR-132-3p, miR-134-5p, and miR-212-3p) target proteins that regulate transcription in response to synaptic activity.

The BDNF-related gene MeCP2 is a putative dendritic growth regulator that mediates transcriptional repression. [@B72] have shown that a lack of activity-induced phosphorylation of MeCP2 causes enhanced LTP. As described above, both miR-132-3p and miR-212-3p interact with MeCP2 ([@B57]; [@B47]). Excluding the role of BDNF in the circuit, there is evidence of reciprocal inhibition between MeCP2 and miR-132-3p/212-3p ([@B57]; [@B41]; [@B47]; [@B120]). Furthermore, MeCP2 knockdown in HEK293 cells increased miR-212-3p and miR-132-3p expression ([@B47]). This conflicts with other evidence showing MeCP2 knockout *in vivo* decreased miR-132-3p levels ([@B57]), but may be explained by the different preparations used. Further studies are needed to investigate these complex interactions involving MeCP2 in the context of LTP.

Another transcriptional repressor linked to LTP is Sirtuin 1 (SIRT1; [@B85]) which can be directly inhibited by miR-34c-5p ([@B137]). In a study comparing young and aged mice, endogenous miR-34c-5p decreased SIRT1 protein in the hippocampus of aged, but not young, mice *in vivo* ([@B137]). Over-expression of miR-34c-5p in the young mice caused a decrease in SIRT1 protein. Furthermore, in two memory impairment mouse models (aged and APPS1-21), an increase in miR-34c-5p was correlated with decreased SIRT1 protein ([@B137]). Intrahippocampal injection of miR-34 inhibitors restored the level of SIRT1 protein in the APPS1-21 mice. The finding that miR-34c-5p is differentially expressed in a mouse model of AD supports the hypothesis that miR-34c-5p down-regulation is necessary for memory. In keeping with this hypothesis, increased miR-34c-5p expression was correlated with impaired contextual fear conditioning in mouse models of aging and AD and was rescued with miR-34c seed inhibitors ([@B137]). However, while SIRT1 was the only target of miR-34c-5p that was investigated in this study, the authors note that other targets of miR-34c-5p are likely to be involved.

Interestingly, while miR-34c-5p regulates SIRT1, SIRT1 itself regulates miR-134-5p. In mouse neural cells, knockdown of SIRT1 increased miR-134-5p expression, which in turn inhibited cAMP response element binding protein (CREB) protein expression ([@B38]). *In vivo* miR-134-5p over-expression in the mouse hippocampus mimicked this effect ([@B38]). Furthermore, miR-134-5p is also regulated by an activity-dependant transcription factor, myocyte enhancer factor-2 (Mef2), which negatively regulates the number of excitatory synapses in mature hippocampal neurons ([@B34]). Endogenous Mef2 is required for the depolarization-induced transcription of the miR-379-410 cluster, which contains miR-134 ([@B33]). Inhibition of Mef2 in rat hippocampal neurons followed by depolarization caused a decrease in the precursors of miR-134-5p, which may lead to decreased mature miR-134-5p, affecting its ability to regulate its targets such as CREB. However, these interactions of miRNA and memory-related transcription regulators are yet to be studied in an LTP paradigm.

As a key regulator of activity-dependent dendritic morphogenesis, CREB mediates LTP-induced transcription, in part though the activation of an array of other transcription factors, which bind to specific response elements in immediate early genes (IEGs) such as early growth response 1 (EGR1). Both CREB and EGR1 have been linked to miRNA. MiR-124-3p directly decreased EGR1 expression *in vivo* ([@B133]) and CREB expression *in vitro* ([@B98]). MiR-134-3p directly decreased CREB expression *in vitro* ([@B38]). These miRNA:mRNA interactions are intriguing, but are yet to be validated in a mammalian LTP model.

MicroRNA REGULATE DENDRITOGENESIS
---------------------------------

The majority of excitatory synapses in the mammalian brain are formed on specialized protrusions from dendrites, known as spines. Dendritic spines exhibit actin-dependent morphological plasticity and their size has been correlated with synaptic strength ([@B80]). LTP3 consolidation, and long-term storage of memories, may be achieved by an increase in the size, and therefore strength, of potentiated synapses. Dendritic morphogenesis may allow synapses to maintain their enhanced strength for long periods, in spite of continual turnover of their constituent proteins. Specific miRNA regulate transcripts that code for proteins involved in the regulation of dendritic spine morphology, which may underlie LTP maintenance.

MiR-134-5p interacts with the translational regulatory protein, pumilio homolog 2 (Pum2), which mediates activity-dependent dendritogenesis. Pum2 is an RNA-binding protein that regulates translation and mRNA stability by binding the 3^′^UTR of mRNA targets. MiR-134-5p directly targets Pum2 in membrane-depolarized rat cortical neurons, but not under basal conditions, suggesting only newly processed miR-134-5p interacts with Pum2 ([@B33]). Furthermore, miR-134-5p buffers Pum2 protein levels within a narrow range necessary for activity-dependent dendritogenesis ([@B33]), suggesting that miR-134-5p-mediated regulation of Pum2 may be critical for the structural changes that underlie LTP maintenance. This proposal is supported by *in vivo* evidence ([@B22]).

In contrast, miR-134-5p has been found to decrease spine volume in hippocampal neurons under normal conditions ([@B107]). MiR-134-5p has been shown to interact with LIM domain kinase 1 (Limk1), a serine/threonine kinase that regulates actin polymerization by inactivating cofilin neurons ([@B107]). Limk1 knockout mice exhibit dendritic spine structural abnormalities and enhanced LTP ([@B83]). Over-expression of miR-134-5p in normal mice impaired LTP persistence and performance in learning paradigms including fear conditioning, Morris water maze, and novel object recognition ([@B38]). Performance in these tasks and LTP persistence were rescued when miR-134-5p was knocked down. However, whether this rescue was mediated by Pum2 and/or Limk1, or other miR-134-5p targets is unknown.

MiR-132-3p regulates existing spine growth in neurons *in vitro* by directly inhibiting translation of p250GAP in a Rac1- and kalirin-7-dependent manner ([@B30]; [@B48]; [@B82]). *In vitro* and *in vivo* studies suggest that the effect of miR-132-3p on spine morphology differs according to the developmental stage of the neuron: miR-132-3p triggers spine formation during the spine development phase, and increases the volume of existing spines once the majority of spines have developed ([@B30]; [@B41]; [@B48]; [@B79]; [@B82]; [@B120]). Whether these effects of miR-132-3p on existing spines contribute past development to underlie LTP-related structural changes remains to be seen. Furthermore, over-expression of miR-132-3p leads to the formation of spines with low plasticity properties: the mushroom spines of stable mature spines, and immature filopodia ([@B82]; [@B120]; [@B119]). This suggests that like miR-134-5p, an optimal range of miR-132-3p expression is required for plasticity-induced spine changes to occur.

MiR-138-5p has been found to decrease spine size in rat hippocampal neurons by directly targeting an enzyme co-localized at the synapse, called acyl-protein thioesterase 1 (APT1; [@B8]; [@B113]). APT1 catalyzes the depalmitoylation of signaling proteins, a lipid modification that can affect not just the function of the protein but its localization; the latter is particularly important considering the extent of neuronal processes. By inhibiting APT1, miR-138-5p was found to increase the membrane localization of the G-protein Gα~13~, thus activating the downstream Rho signaling pathway, which has been implicated in spine morphology regulation ([@B117]). MiRNA also regulate other pathways involved in spine morphogenesis, in addition to G-protein signaling pathways. MiR-19b-3p inhibits PTEN (phosphatase and tensin homolog), a modulator of the AKT-mTOR signaling pathway, which controls dendritic development and synapse formation ([@B64]). MiR-19b-3p was up-regulated in mouse CA1 tissue 3 h after fear conditioning and in cultured hippocampal neurons 1 h after NMDA stimulation (but not bicuculline stimulation). Based on this research, [@B64] proposed that learning induces miR-19b-3p, which inhibits PTEN and prevents it dephosphorylating phosphoinositide-3-kinase (PI3K). This in turn releases inhibition of the mTOR pathway, leading to increased protein synthesis. In keeping with this theory, miR-19b-3p has been shown to increase total neurite length in hippocampal neurons ([@B64]). A number of other miRNA that are up-regulated in response to fear conditioning and neural stimulation are known to increase mTOR-dependent protein synthesis via PTEN or Fox01 regulation (miR-21-5p, miR-22-3p, miR-27a-3p, miR-106b-5p, miR-139-5p), but these miRNA were not investigated further in [@B64].

As mentioned above, miR-188-5p is down-regulated 2 h after LTP induction in rat hippocampal slices ([@B68]). In this study, it was found that miR-188-5p directly inhibited neuropilin 2 (Nrp2), a transmembrane receptor protein for class 3 semaphorins, which have been shown to be chemorepellents against axonal growth cones, and therefore may act in a similar way against growth cones for dendritic spines. An increase in Nrp2 induced a decrease in spine density in hippocampal neurons, but miR-188-5p application rescued this effect. Over-expression of miR-188-5p does not have the expected effect of increasing spine density; the authors suggested this may have been due to a saturation effect ([@B68]).

Five other miRNA have been shown to regulate dendritic spine morphology in DIV 10--15 rat hippocampal neurons: miR-125b-5p ([@B30]), miR-181a-5p ([@B103]), miR-485-5p ([@B23]), miR-329-3p, and miR-381-3p ([@B33]). The latter study is particularly interesting, as it reported that miR-329-3p and miR-381-3p were necessary for activity-dependent increases in dendritic complexity, but application of these miRNA had no effect under basal conditions. This result suggests that these miRNA may play a role in activity-dependent dendritogenesis.

Collectively, these results indicate that a sub-set of miRNA regulates translation of several proteins that are involved in dendritic morphogenesis. While, in some cases, these interactions have been investigated in the context of LTP, research into the role of miRNA in dendritic morphogenesis has focused on the genesis of new spines in developing neurons. These same miRNA:mRNA interactions may also play a role in the growth of existing spines in adult neurons during LTP maintenance, but further research is required to test this hypothesis.

DISCUSSION
==========

This review has summarized current knowledge regarding the possible involvement of miRNA in LTP maintenance. We presented evidence that a subset of miRNA are differentially expressed between 20 min and 5 h after induction of LTP *in vivo* and converging lines of evidence suggesting that miRNA likely regulate the expression of proteins relevant to all aspects of LTP maintenance.

Key properties of miRNA -- pleiotropism, tight regulation, synaptic localization, and responsiveness to activity -- make them ideal candidates as regulators of the co-ordinated gene expression that underpins LTP maintenance. Some of these properties are shared with other non-coding RNA, which have also been implicated in the maintenance of memory ([@B84]). The hypothesis that miRNA regulate LTP maintenance is underscored by the studies presented in this paper and clearly demonstrated in **Figure [2](#F2){ref-type="fig"}**, which shows the influence of individual miRNA on multiple LTP-related genes. For example, miR-132-3p has been linked to glutamate receptor expression, dendritogenesis and transcription factor regulation. In keeping with these results, miR-132-3p has been implicated in learning behavior *in vivo*: over-expression of miR-132-3p in mouse forebrain neurons was associated with deficits in novel object recognition ([@B41]) and contextual fear conditioning increased pri-miR-132 expression ([@B89]).

There is strong evidence that miRNA fine-tune translation locally at activated synapses ([@B107]; [@B19]): miR-134-5p inhibits translation of Limk1 at the synapse until synaptic activation, at which point miR-134-5p is inactivated and Limk1 protein is expressed, leading to dendritic spine growth. Conversely, synaptic activation could trigger miRNA to suppress translation of synaptic proteins that prevent LTP maintenance. Either or both of these mechanisms would allow miRNA to couple synaptic activity to the selective protein synthesis that contributes to LTP2 and/or LTP3. This is consistent with the reported changes in miRNA expression post-LTP and the localisation of miRNA and proteins involved in miRNA biogenesis and function at synapses ([@B75], [@B76]; [@B107]; [@B63]; [@B6]; [@B113]; [@B87]). There is, however, no direct evidence that miRNA affect local protein synthesis at the synapse and thereby contribute to the input specificity of LTP.

MiRNA may also affect the translational ability of mRNA transcripts as they are being transported from the soma to the axonal terminals or dendritic spines ([@B107]). There is evidence that miRNA may be bound to mRNA in structures similar to processing-bodies (P-bodies) for transportation, allowing the miRNA to suppress translation of the mRNA until after synaptic activation ([@B107]). The transcripts are likely to encode proteins that stabilize the changes at synapses that allow LTP to persist. For example, over-expression of miR-132-3p can result in increased levels of the NMDA receptor subunits GluN2A and GluN2B ([@B53]) and our own research has shown that post-LTP there is a rapid protein synthesis-dependent, transcription-independent increase in their expression ([@B128]).

That miRNA play a role in LTP-maintenance outside of the synapse is supported by evidence that miRNA influence the expression of LTP-related transcription regulators such as CREB, EGR1, MeCP2, SIRT1 and Mef2, contributing to the coordinate genomics response which underpins LTP3 by allowing tight regulation of a subset of genes post-LTP induction ([@B102]; [@B49]).

It is important to note that regulation of miRNA in response to LTP induction does not prove that they contribute to LTP maintenance. There are currently no reports of a direct effect of altering miRNA activity on LTP maintenance. Indeed, Dicer knockdown and concomitant down-regulation of miRNA had no effect on LTP ([@B59]), however, this could be attributed to the short recording time of 50 min after HFS. By contrast, over-expression of individual miRNA *in vivo* prior to LTP induction was associated with a decrease in LTP ([@B38]; [@B108]), although these studies could not determine whether this affected LTP maintenance or LTP induction as the miRNA levels were altered prior to the induction of LTP. We also cannot rule out the possibility that miRNA regulation is occurring outside of neurons (e.g., in glia), or at synapses that are not undergoing LTP. Indeed, the observed changes in miRNA expression could be due to related forms of activity-dependent synaptic plasticity, such as LTD or depotentiation. For example, NMDA receptor-dependent LTD requires miR-191a-5p and miR-135a-3p for its maintenance ([@B45]), and electroconvulsive shock (ECS), which shares many properties with LTP, can induce differential expression of a large number of miRNA ([@B28]). These forms of synaptic plasticity are likely to be activated concurrently to scale synapses in neighboring spines, dendrites, or neurons. Further research accounting for cell type and/or sub-cellular compartments is needed to resolve these issues.

An important next step for this field is to confirm that the miRNA:mRNA interactions presented here are indeed physiologically relevant to LTP maintenance, either *in vitro* or *in vivo*. Likewise, conditional regulation of miRNA levels or activity is required to discriminate between effects on the early and late phases of LTP. Furthermore, investigation of the mechanisms underpinning altered miRNA turnover and/or synthesis, particularly with regard to rapid down-regulation of miRNA is required. To establish the full cohort of LTP-related miRNA, high-throughput broad screens of differentially expressed miRNA at multiple time points after LTP induction are needed. Alongside this the development of improved target prediction algorithms would facilitate identification of relevant targets of these miRNA, and thereby increase our understanding of the functional significance of miRNA regulation in response to LTP induction.

SUMMARY
=======

We conclude that to date, there is insufficient evidence to confirm that miRNA contribute to the maintenance of LTP; seven studies from four groups have reported differential expression of miRNA in response to LTP induction and converging lines of evidence suggest that they are ideally suited to this purpose. The functional significance of miRNA in the maintenance of LTP remains to be determined; this is the next step in this challenging and exciting area of research.
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